A Retrospective Clinical Study on the First-line Maintenance Treatment of PTCL With Chidamide.

Nanjing Medical University

Status: Enrolling

Conditions: PTCL

Treatments: Drug: chidamide

Study type: Observational

Funder types: Other

Identifiers

NCT05967949

CS123

Details and patient eligibility

About

The efficacy and safety of chidamide in first-line maintenance therapy for PTCL will be assessed through a retrospective case analysis.

Full description

The study design belongs to a retrospective study, collecting information on patients with PTCL who were diagnosed and treated with chidamide as maintenance therapy at our center. The collected data includes age, gender, previous treatment regimens, results of auxiliary examinations (such as blood routine, biochemistry, bone marrow cytology, pathology, flow cytometry, NGS, etc.), as well as PET-CT images. The safety and efficacy of Chidemide as first-line maintenance therapy in PTCL will be analyzed.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• (1) Age: 18 years and older; (2) Gender: Male/Female; (3) Diagnosed with PTCL; (4) Received chidamide as maintenance therapy after first-line treatment.

Exclusion criteria

• (1) Patients with other types of lymphomas; (2) Pregnant women.